IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Ernexa Therapeutics Inc (ERNA)

CUSIP: 114082407 | NYSE | Healthcare · Biotechnology | Micro Cap | 14 institutional holders

Quarters

Q3 2026Q2 2026
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13G/AFreebird Partners LP119,0157.0%New 5%+ stakeAug 5, 2026No 13F filer matched
13G/AFreebird Partners LP119,015
7.0% of class · Aug 5, 2026

Institutional Holders — Q3 2026

Geode Capital Management, LLC16,077
0.0% of portfolio›$51.4K
Tradewinds Capital Management, LLC4,609
0.0% of portfolio›$14.7K
Citigroup Inc102
0.0% of portfolio›$326
UBS Group AG19
0.0% of portfolio›$61
Assetmark, Inc5
0.0% of portfolio›$16
SBI Securities Co., Ltd.1
0.0% of portfolio›$3
StyleTurnoverLocationFiled
Geode Capital Management, LLC
16,077$51.4K0.0%IndexVery LowBoston, MA2026-11-06
Tradewinds Capital Management, LLC
4,609$14.7K0.0%ETFVery HighBellingham, WA2026-10-23
Citigroup Inc
102$3260.0%CoreMediumNew York, NY2026-11-04
UBS Group AG
19$610.0%CoreMediumZurich, Switzerland2026-11-10
Assetmark, Inc
5$160.0%ETFLowConcord, CA2026-10-21
SBI Securities Co., Ltd.
1$30.0%GrowthLowTokyo, Mexico2026-10-22
New 5%+ stake
No 13F filer matched